8:00 – 9:00 Registration and coffee (at the Aula)
Chair: Hans Hogerzeil
| At the Festsaal | |
|---|---|
| 09:00 – 09:30 |
Welcome
|
| 09:30 – 10:30 | Pharmaceutical policies in a changing world – key statements from players in pharmaceutical systems |
Chair: Hans Hogerzeil
|
|
| 10:30 – 11:00 | Coffee break (at the Aula) |
| 11:00 – 12:00 |
Key note presentation – Solidarity and innovation Erik Schokkaert, Department of Economics, K.U. Leuven Download |
| 12:00 – 13:00 | Lunch (at the Aula) |
Parallel sessions
| At the Festsaal |
At the Sitzungssaal (number of participants is limited!) |
At the Theatersaal (opposite the venue location at Sonnenfelsgasse 19) |
|
|---|---|---|---|
| 13:00 – 14:30 |
Pricing and reimbursement policies in the light of the financial crisis Chair: Kees de Joncheere, WHO Regional Office for Europe |
The hospital setting as key sector - Interface management Chair: Roberto Frontini, European Association of Hospital Pharmacists |
How to interpret and compare pharmaceutical prices Chairs: Claudia Habl, Bettina Schmickl, GÖG |
|
|
||
| 14:30 – 15:00 | Coffee break (at the Aula) | ||
| 15:00 – 16:30 |
Pharmaceutical pricing policies Chair: Elizabeth Docteur, Elizabeth Docteur Consulting, USA |
Experiences with pharmaceutical profiles Chair: Nina Zimmermann, GÖG |
Commercial aspects of rational use Chair: Richard Laing, WHO Headquarters |
| At the Festsaal | |
|---|---|
| 16:40 – 17:30 |
Key note presentation - Access to High Cost Medicines, examples from the Americas Alexandre Lemgruber, The Pan American Health Organisation Download |
| 17:30 – 19:00 | Reception at the Aula (open to all participants) |
| At the Theatersaal | |
|---|---|
| 08:00 – 08:45 | Meet editors of journals in the pharmaceutical field – question and answer session |
Chair: Claudia Habl (WHO CC, GÖG)
| At the Festsaal | ||||
|---|---|---|---|---|
| 09:00 – 09:40 |
Pricing and reimbursement of medicines – a European overview Sabine Vogler, GÖG Download |
|||
| 09:50 – 11:00 | Parallel poster sessions: Presentations of country examples of pharmaceutical systems | |||
| At the Festsaal |
At the Theatersaal (opposite the venue location at Sonnenfelsgasse 19) |
At the Sitzungssaal | At the Aula | |
|
Western and Nordic countries Chair: Sveinbjörn Högnason, Icelandic Medicine Pricing and Remibursement Committee |
Central and Eastern Europe Chair: Jan Mazag, SUKL Slovakia |
Mediterranean countries (incl. FR) Chair: Miguel Gomes, INFARMED Portugal |
World perspective Chair: Joan Rovira, Barcelona University, Spain |
|
| 09:50 – 10:05 |
Germany (Silke Baumann, Ministry of Health)
Download |
Latvia (Janis Innus, Centre of Heath Economics)
Download |
France (Sophie Lopes, CNAMTS)
Download |
|
| 10:05 – 10:20 |
United Kingdom (David Kullmann, Department of Health)
Download |
Poland (Jakub Adamski, Ministry of Health)
Download |
Greece (Lena Katsomiti, Greek Ministry of Health)
Download |
|
| 10:20 – 10:35 |
Finland (Jaana Martikainen, The Social Insurance Institution)
Download |
Hungary (Judit Bidló, National Health Insurance Dund Administration)
Download |
Spain (Piedad Ferre, Ministry of Health)
Download |
|
| 10:35 – 11:00 | Discussion on differences and similarities | Discussion on differences and similarities | Discussion on differences and similarities | |
| Coffee break (at the Aula) | ||||
| 11:30 – 13:00 | Parallel abstract presentations and poster session | |||
| At the Festsaal | At the Sitzungssaal |
At the Theatersaal (opposite the venue location at Sonnenfelsgasse 19) |
||
|
Pricing and reimbursement of medicines Chairs: Jaime Espin, Andalusian School of Public Health (EASP), Christine Leopold, GÖG |
Hospital pharma - Interface management Chairs: Øyvind Melien, Norwegian Directorate of Health, Ján Mazag, SUKL - State Institute for Drug Control, Slovakia |
Rational use of medicines Chairs: Aukje Mantel-Teeuwisse, Utrecht University, Anita Wagner, WHO CC Boston University |
||
| 11:30 – 11:45 |
Abstract # 85: Cost containment interventions introduced on the community drug schemes in Ireland - evaluation of expenditure trends using a national prescription claims database. (Cara Usher, National Centre for Pharmacoeconomics, Ireland) Download |
Abstract # 67 Enhancing the utilisation of generic clopidogrel: a case history for future guidance? (Christoph Baumgaertel, AGES PharmMed, Austrian Medicines and Medical Devices Agency, and Kristina Garuoliené, National Health Insurance Fund under the Ministry of health of the Republic of Lithuania) Download |
The need for generic policies as part of health reform (Richar Laing, WHO Headquarters) Download |
|
| 11:45 - 12:00 |
Abstract # 91 Income Concentration and Price Differentiation in Low and Middle Income Pharmaceutical Markets (Eric L. Keuffel, Fox School of Business (Temple University), USA) Download |
Abstract # 96 Influence of hospital choices of competitive drugs on the pharmaceutical consumption in the community (Adeline Gallini, University of Toulouse, France) Download |
Abstract # 56 Potential methods to enhance prescribing efficiency, implications for sustaining healthcare systems (Brian Godman - Division of Clinical Pharmacology, Karolinska Institutet, Sweden, Prescribing Research Group, Liverpool University, UK) Download |
|
| 12:00 - 12:15 |
Abstract # 64 Performance of drug reimbursement systems: a comparison of the Austrian, Belgian, Dutch, French and Swedish systems (Margreet Franken, Institute for Health Policy and Management, Erasmus University Rotterdam, The Netherlands) Download |
Abstract # 52 Do European rheumatoid arthritis patients have equal access to treatment with new medicines? (Joëlle M. Hoebert, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands) Download |
Health Care and Medicines Need and Access: Are there Gender Inequities? (Anita Wagner, Harvard Medical School and Harvard Pilgrim Health Care institute, USA) Download |
|
| 12:15 - 12:30 |
Poster presentations
Prices and affordability of medicines in Armenia (Margit Melikyan, Drug Utilisation
Research Group Armenia)
Access to innovative anticancer drugs in the outpatient setting in Latvia (Marta
Kipena, The Centre of Health Economics, Latvia)
Development of benchmarks to improve price negotiations of antiretroviral medicines
for low and middle iincome countries (Veronika Wirtz, National Institute of Public
Health, Mexicao) |
Poster presentations
Characteristics of medicines management in Austrian hospitals (Elfriede Dolinar,
Vienna General Hospital, Austria)
Access to high cost medicines: a systematic review of the literature (Philip Wahlster,
University of Auckland, University of Greifswald, Germany) |
Poster presentations
Report Cards on Prescribing Behavior: Assessing the Impacts of Public Disclosure
on Antibiotic Prescribing Rate (Seemoon Choi, Department of Global Health and population,
Harvard School of Public Health, USA)
High rate of self purchasing of oral antibiotics in Serbia: implications for future
policies (Marija Kalaba, Republic Institute for Health Insurance, Republic of Serbia)
Essential to review health policy initiatives when comparing utilisation patterns
across countries? (Brian Godman, Division of Clinical Pharmacology. Karolinska Institute,
Sweden Presribing Research Group, Liverpool University, UK) |
|
| 12:30 - 13:00 | Poster walk | |||
| 13:00 – 14:00 | Lunch (at the Aula) | |||
Chair: Sabine Vogler, GÖG
| At the Festsaal | |
|---|---|
| 14:00 – 14:45 |
Key note presentation - Pricing and reimbursement of medicines from global perspective Andreas Seiter, World Bank Download |
| 14:45 – 15:45 |
Panel discussion: The way forward - reflections and future directions Chair: Sabine Vogler, GÖG
|
| 15:45 – 16:00 |
Closing addresses Karin Kadenbach, Member of the European Parliament, Austria Sabine Vogler, WHO CC, Austrian Health Institute - GÖG |